NCT07466277

Brief Summary

This study aims to investigate the therapeutic effects of intermittent theta burst stimulation on social anxiety disorder and to track physiological changes in the brain using electroencephalography (EEG). Eligible SAD participants, after voluntarily signing an informed consent form, will first complete basic information collection, baseline questionnaire completion, and a pre-treatment EEG data collection session lasting approximately 30 minutes (including resting-state and task-state recordings). Subsequently, participants will be randomly assigned to one of three groups (left iTBS group, right iTBS group, or sham stimulation group) to receive intensive treatment for one week (4 sessions daily for 5 consecutive days, totaling 20 sessions). Immediately following the intervention, the research team will conduct post-treatment EEG data collection and gather questionnaire assessments. Participants will also undergo follow-up visits at weeks 2, 4, 6, and 8 post-treatment to complete questionnaires and report any adverse events. All study procedures are strictly and safely conducted by trained professionals. Participation is entirely voluntary, and participants may withdraw unconditionally at any time during the study.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
6mo left

Started Dec 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress53%
Dec 2025Dec 2026

Study Start

First participant enrolled

December 9, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 4, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 12, 2026

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

March 12, 2026

Status Verified

December 1, 2025

Enrollment Period

12 months

First QC Date

March 4, 2026

Last Update Submit

March 11, 2026

Conditions

Keywords

Social Anxiety DisorderTranscranial Magnetic StimulationIntermittent Theta-Burst StimulationPrefrontal Cortex

Outcome Measures

Primary Outcomes (1)

  • Change from Baseline in Liebowitz Social Anxiety Scale (LSAS) Total Score

    The LSAS is used to assess the severity of social anxiety symptoms by evaluating fear and avoidance across multiple social and performance situations. The total score ranges from 0 to 144. Higher scores indicate greater severity of social anxiety symptoms (worse outcome).

    Baseline, immediately post-intervention (Week 1), and at Weeks 2, 4, 6, and 8 post-intervention.

Secondary Outcomes (4)

  • Change from Baseline in Hamilton Anxiety Rating Scale (HAMA) Total Score

    Baseline, immediately post-intervention (Week 1), and at Weeks 2, 4, 6, and 8 post-intervention.

  • Change from Baseline in Hamilton Depression Rating Scale (HAMD) Total Score

    Baseline, immediately post-intervention (Week 1), and at Weeks 2, 4, 6, and 8 post-intervention.

  • Change from Baseline in Pittsburgh Sleep Quality Index (PSQI) Score

    Baseline, immediately post-intervention (Week 1), and at Weeks 2, 4, 6, and 8 post-intervention.

  • Change from Baseline in Resting-State and Task-State Electroencephalogram (EEG) Metrics

    Baseline and immediately post-intervention (Week 1).

Study Arms (3)

Left PFC-iTBS

EXPERIMENTAL

Participants will receive active intermittent theta-burst stimulation (iTBS) targeting the left prefrontal cortex.

Device: Active Intermittent Theta-Burst Stimulation (iTBS)

Right PFC-iTBS

EXPERIMENTAL

Participants will receive active intermittent theta-burst stimulation (iTBS) targeting the right prefrontal cortex.

Device: Active Intermittent Theta-Burst Stimulation (iTBS)

Sham iTBS

SHAM COMPARATOR

Participants will receive sham intermittent theta-burst stimulation (iTBS) targeting the prefrontal cortex.

Device: Sham Intermittent Theta-Burst Stimulation (iTBS)

Interventions

Active iTBS is delivered using a real "figure-8" coil targeting the prefrontal cortex. Stimulation is delivered at 120% of the resting motor threshold (RMT). The protocol consists of 3 sets of 50 Hz pulses repeated at 5 Hz (2s on, 8s off), totaling 1,800 pulses per session. The intensive treatment schedule includes 4 sessions per day for 5 consecutive days (1 week), totaling 20 sessions.

Left PFC-iTBSRight PFC-iTBS

Sham iTBS is delivered using a visually identical sham "figure-8" coil. It produces similar acoustic clicks and scalp somatic sensations to mimic the active treatment, ensuring participant blinding. However, it uses same-direction currents causing opposing central currents, resulting in near-zero focal magnetic induction without therapeutic effect. The session schedule and apparent parameters strictly match the active group (4 sessions/day for 5 days).

Sham iTBS

Eligibility Criteria

Age16 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Second Affiliated Hospital, School of Medicine, Zhejiang University

Hangzhou, Zhejiang, 310013, China

RECRUITING

MeSH Terms

Conditions

Phobia, Social

Condition Hierarchy (Ancestors)

Phobic DisordersAnxiety DisordersMental Disorders

Study Officials

  • Lei Lei Zheng, MD

    Second Affiliated Hospital, School of Medicine, Zhejiang University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Eligible participants will be randomly assigned to one of three parallel arms in a 1:1:1 ratio: active left PFC-iTBS, active right PFC-iTBS, or sham iTBS. Each participant will receive the designated intervention for 1 week (20 sessions total) and remain in their originally assigned arm throughout the intervention and the subsequent 8-week follow-up period.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 4, 2026

First Posted

March 12, 2026

Study Start

December 9, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

March 12, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share

De-identified individual participant data (IPD) that underlie the results reported in this article will be shared. This includes clinical assessment scores and extracted neurophysiological (EEG) feature data.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Data will become available beginning 9 months and ending 36 months following article publication.
Access Criteria
Data will be shared with researchers who provide a methodologically sound proposal to achieve aims in the approved proposal. Proposals should be directed to the corresponding author. To gain access, data requestors will need to sign a formal data access agreement, ensuring compliance with local data protection regulations regarding sensitive psychiatric data.

Locations